查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829233

2025年基于横向流动免疫检测（LFIA）的快速检测全球市场报告

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，基于侧流免疫检测(LFIA) 的快速检测市场急剧下滑，从 2024 年的 80.3 亿美元下降至 2025 年的 71.7 亿美元，复合年增长率为 -10.7%。过去几年的下滑主要归因于灵敏度和特异性有限、多重检测的复杂性、交叉反应问题、储存和保质期挑战以及定量分析能力有限。

预计未来几年，基于侧流免疫检测(LFIA) 的快速检测市场将稳定成长，到 2029 年将达到 81.2 亿美元，复合年增长率为 3.2%。预测期内的下降可归因于全球供应链中断、监管挑战、竞争加剧、替代技术的出现以及与数位健康平台的整合。预测期间的主要趋势包括：开发用于多次或重复 LFIA 快速检测及其结果储存和通讯的先进技术；更重视伙伴关係关係和合作研究；开发家用检测套组；投资基于人工智慧的疾病筛检和检测方法；以及开发患者可轻鬆取得且价格低廉的检测套组。

侧流免疫检测(LFIA) 快速检测是一种简单的技术主导诊断设备，用于检测人体样本中是否存在特定目标，例如病原体或生物标记。这些样本包括各种体液，如尿液、唾液、血液和汗水。

主要方法包括竞争性检测法、夹心法和多重检测法。竞争性检测法特异性检测采集样本中是否存在目标物质，例如病原体或生物标记。其应用领域包括感染疾病、怀孕和不孕症评估以及毒理学，并可应用于医院、诊所、诊断实验室和居家医疗等各种环境。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供了基于横向流动免疫检测(LFIA) 的快速免疫检测市场统计数据，包括全球市场规模、各地区份额、基于横向流动免疫检测分析(LFIA) 的快速检测市场份额的竞争对手、基于横向流动免疫检测免疫检测(LFIA) 的快速检测市场、市场、市场和细分市场（这份基于横向流动免疫检测(LFIA) 的快速检测市场研究报告透过深入分析产业现况和未来情势，为您提供全面的观点。

我们预测未来五年该市场将成长3.2%，较先前预测略有下降1.8%。下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自丹麦和巴西等主要地区的单株抗体检测线和样品垫片材料征收关税直接影响美国，从而导致就地检验的可用性降低，并增加传染病筛检的成本。由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响，影响可能会更加广泛。

品管是阻碍侧流免疫检测(LFIA) 快速检测市场成长的关键挑战。包括工资和技术投资在内的营运成本不断上升，正在挤压许多公司的利润率。例如，2023 年 6 月，美国非营利组织 PLOS 的一份报告强调，市面上的 LFIA 产品并非始终符合高可靠性和特异性标准。一项针对四项 LFIA 检测的回顾性评估显示，其诊断效能存在相当大的差异，一些检测对 IgG 检测的准确率甚至低至 47%。

由于慢性病的盛行率不断上升，基于侧流免疫检测(LFIA) 的快速检测市场预计将持续成长。这些长期健康状况需要早期发现、就地检验和定期监测，而基于 LFIA 的快速检测能够快速提供结果并有助于管理慢性病。世界卫生组织 (WHO) 报告称，非传染性疾病 (NCD) 每年导致大量死亡，这凸显了 LFIA 在治疗心血管疾病、癌症、慢性呼吸系统疾病和糖尿病等疾病方面的作用。因此，慢性病盛行率的上升推动了市场的发展。

基于侧流免疫检测(LFIA) 的快速检测市场的主要企业正专注于定量聚合酵素链锁反应(qPCR) 等技术，以提高检测灵敏度和特异性，加快检测速度，并扩大可识别的病原体和生物标誌物的范围。 qPCR 技术是一种分子生物学技术，用于即时扩增和定量 DNA 或 RNA 序列，从而能够精确测量基因表现量并检测各种样本中的特定病原体。例如，2023 年 11 月，瑞士製药公司 F. Hoffmann-La Roche 宣布推出 LightCycler PRO 系统。该系统基于罗氏的 qPCR 技术开发，采用黄金标准技术，实现高品质、高精度和高可靠性，这对于准确的患者诊断和有效的临床决策至关重要。

侧流免疫检测(LFIA) 快速检测市场的主要企业也在投资综合健康解决方案，旨在透过改进跨医疗平台的数据共用和协作来提高诊断效率、优化工作流程并提供全面的患者照护。综合健康解决方案包含一个综合医疗保健系统，该系统连接各种服务、技术和数据，以改善患者照护并简化营运。例如，2024 年 6 月，罗氏公司 (F. Hoffmann-La Roche AG) 推出了其 Cobas Pro 综合解决方案的分析单元。 Cobas Pro 系统配备一个每小时最多可处理 1,000 个样本的样本供应单元、一个每小时最多可进行 900 次测试的离子选择电极 (ISE) 以及一个专门用于临床化学的 Cobas C 503 单元，每小时最多可进行 1,000 次测试。

2023年8月，丹纳赫集团以57亿美元收购了Abcam，这符合丹纳赫强化其生命科学业务的策略。 Abcam是一家专注于基于LFIA的快速检测的英国生技公司，此次收购预计将提升股东价值，并为员工和客户带来卓越的成果。

以横向流动免疫检测(LFIA) 为基础的快速检测市场的主要企业包括雅培实验室、F. Hoffmann-La Roche、Quidel Corporation、Becton, Dickinson and Company、丹纳赫公司、西门子股份公司、赛默飞世尔科技公司、Bio-Rad Laboratories, Inc.、PerkinElmer Inc.、Hologic, Inc.、UIO,LTEK 股份有限公司Biotechnology、江苏美多美医疗技术有限公司、Diagnocure、Ubio Biotechnology Systems、Elabscience® Immunoassay Kits、FyoniBio/Glycotope GmbH、Atomo Diagnostics Limited、INDICAL Bioscience、Lionex Gmbh、BIOMED Lgnostator GunchakHdiaostto Ltd、Qiagen NV、默克集团、XPhyto Therapeutics、3a Diagnostics、罗氏控股公司、BATM、Biomaxima、SensDx Vitrosens Biotechnology、Bioeasy Biotechnology、Fujirebio、Immunodiagnostic Systems Holdings PLC、Mesa Biotech Inc、CTK Biotech。

2024年，基于侧流免疫检测(LFIA) 的快速检测市场最大的地区是北美。亚太地区是全球基于侧流免疫检测(LFIA) 的快速检测市场的第二大地区。侧流免疫检测(LFIA) 的快速检测市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美、中东和非洲。

基于横向流动免疫检测(LFIA) 的快速检测市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、加拿大和西班牙。

基于侧流免疫检测(LFIA) 的快速检测市场包括结合垫片、硝酸纤维素膜和吸收垫片的销售。该市场的数据为出厂价，即商品由製造商或生产者销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终消费者的价值。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 基于全球横向流动免疫检测(LFIA) 的快速检测：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球基于横向流动免疫检测(LFIA) 的快速检测市场：成长率分析
  • 全球基于横向流动免疫检测(LFIA) 的快速检测市场表现：规模与成长，2019-2024 年
  • 全球基于侧流免疫检测(LFIA) 的快速检测市场预测：规模与成长，2024-2029 年，2034 年
  • 全球基于横向流动免疫检测(LFIA) 的快速检测：总潜在市场 (TAM)

第六章 市场细分

  • 全球基于侧流免疫检测(LFIA) 的快速检测市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 竞争分析
  • 夹心试验
  • 多重检测分析
  • 全球基于侧流免疫检测(LFIA) 的快速检测市场（按应用、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 感染疾病
  • 妊娠和不孕症治疗
  • 毒理学
  • 心臟标记和胆固醇检测
  • 其他的
  • 全球基于侧流免疫检测(LFIA) 的快速检测市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院诊所
  • 诊断实验室
  • 居家医疗
  • 其他的
  • 全球基于侧流免疫检测(LFIA) 的快速检测市场：竞争性检测细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 直接竞争试验
  • 间接竞争试验
  • 全球基于侧流免疫检测(LFIA) 的快速检测市场：夹心法细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 一步夹心试验
  • 两阶段夹心试验
  • 全球基于侧流免疫检测(LFIA) 的快速检测市场：多重检测分析细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 多分析物检测
  • 同时侦测各种目标

第七章 区域和国家分析

  • 全球基于横向流动免疫检测(LFIA) 的快速检测市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球基于横向流动免疫检测(LFIA) 的快速检测市场：国家、绩效及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 基于横向流动免疫检测(LFIA) 的快速侦测市场：竞争格局
  • 基于横向流动免疫检测（LFIA）的快速检测市场：公司简介
    • Abbott Laboratories
    • F. Hoffmann-La Roche
    • Quidel Corporation
    • Becton, Dickinson and Company
    • Danaher Corporation

第31章：其他领先和创新企业

  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.
  • Hologic, Inc.
  • LTEK Co., Ltd.
  • JOYSBIO BIoTechnology
  • Jiangsu Medomics Medical Technologies
  • Diagnocure
  • Ubio BIoTechnology Systems
  • Elabscience（R）Immunoassay Kits
  • FyoniBio/Glycotope GmbH
  • Atomo Diagnostics Limited
  • INDICAL Bioscience
  • Lionex Gmbh

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年基于横向流动免疫检测（LFIA）的快速检测市场：提供新机会的国家
  • 2029年基于横向流动免疫检测（LFIA）的快速检测市场：细分市场带来新机会
  • 2029年基于横向流动免疫检测（LFIA）的快速检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r25741u

The rapid test based on Lateral Flow Immunoassay (LFIA) is a straightforward technology-driven diagnostic device employed for detecting the presence of specific targets, such as pathogens or biomarkers, in samples obtained from the human body. These samples encompass various bodily fluids such as urine, saliva, blood, and sweat.

The primary techniques include the competitive assay, sandwich assay, and multiplex detection assay. The competitive assay specifically determines the presence of targets, such as pathogens or biomarkers, within the collected samples. Its applications span infectious diseases, pregnancy and fertility assessments, toxicology, and others, making it applicable in diverse settings such as hospitals, clinics, diagnostic laboratories, home care, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The lateral flow immunoassay (LFIA) based rapid test market research report is one of a series of new reports from The Business Research Company that provides lateral flow immunoassay (LFIA) based rapid test market statistics, including lateral flow immunoassay (LFIA) based rapid test industry global market size, regional shares, competitors with a lateral flow immunoassay (LFIA) based rapid test market share, detailed lateral flow immunoassay (LFIA) based rapid test market segments, market trends and opportunities, and any further data you may need to thrive in the lateral flow immunoassay (LFIA) based rapid test industry. This lateral flow immunoassay (LFIA) based rapid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lateral flow immunoassay (lfia) based rapid test market size has declined steeply in recent years. It will decline from $8.03 billion in 2024 to $7.17 billion in 2025 at a compound annual growth rate (CAGR) of -10.7%. The decline in the historic period can be attributed to limited sensitivity and specificity, complexity of multiplexing, cross-reactivity issues, storage and shelf-life challenges, limited quantitative capability.

The lateral flow immunoassay (lfia) based rapid test market size is expected to see steady growth in the next few years. It will grow to $8.12 billion in 2029 at a compound annual growth rate (CAGR) of 3.2%. The decline in the forecast period can be attributed to global supply chain disruptions, regulatory challenges, increased competition, emergence of alternative technologies, integration with digital health platforms. Major trends in the forecast period include developing advanced technologies for multiple or repetitive LFIA based rapid test and storage/ communication of results, focus on partnerships and collaborations, develop at home test kits, invest in artificial intelligence-based tests for diseases screening and detection, and should develop low-cost test kits for easy access to patients at low cost.

The forecast of 3.2% growth over the next five years reflects a modest reduction of 1.8% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on monoclonal antibody test lines and sample pad materials, sourced from key regions such as Denmark and Brazil, which could lead to reduced point-of-care testing availability and higher expenses for infectious disease screening.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Quality control continues to be a significant challenge anticipated to impede the growth of the lateral flow immunoassay (LFIA) rapid test market. Rising operational costs, encompassing salaries and technology investments, have strained profit margins for numerous firms. For example, in June 2023, a report from PLOS, a US-based non-profit organization, highlighted that LFIA products available in the market do not consistently adhere to high standards of reliability and specificity. A retrospective assessment of four LFIA tests indicated considerable variability in diagnostic performance, with some tests demonstrating accuracy rates as low as 47% for IgG detection.

The lateral flow immunoassay (LFIA) based rapid test market is set to experience growth fueled by the increasing prevalence of chronic diseases. These long-term health conditions demand early detection, point-of-care testing, and regular monitoring, with LFIA-based rapid tests offering prompt results and aiding in the management of chronic diseases. The World Health Organization reports a significant number of deaths attributed to non-communicable diseases (NCDs) annually, emphasizing the role of LFIA in addressing conditions such as cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes. The market is thus stimulated by the rising incidence of chronic diseases.

Major companies in the lateral flow immunoassay (LFIA)-based rapid test market are concentrating on technologies like qPCR (quantitative polymerase chain reaction) to improve the sensitivity and specificity of their tests, accelerate detection speed, and broaden the range of pathogens or biomarkers that can be identified. This focus aims to lead to more reliable and accurate diagnostic solutions for various healthcare applications. qPCR technology is a molecular biology method used to amplify and quantify DNA or RNA sequences in real time, allowing for precise measurements of gene expression levels or the detection of specific pathogens in various samples. For example, in November 2023, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, introduced the LightCycler PRO System. This system builds on Roche's legacy of qPCR technologies, employing gold-standard techniques to ensure high quality, precision, and reliability-capabilities that are vital for accurate patient diagnosis and effective clinical decision-making.

Leading companies in the lateral flow immunoassay (LFIA)-based rapid test market are also investing in Integrated Health Solutions to enhance diagnostic efficiency, optimize workflows, and deliver comprehensive patient care through improved data sharing and collaboration across healthcare platforms. Integrated Health Solutions encompass comprehensive healthcare systems that link various services, technologies, and data to enhance patient care and streamline operations. For instance, in June 2024, F. Hoffmann-La Roche AG launched analytical units for its Cobas Pro integrated solutions. The Cobas Pro system can process up to 1,000 samples per hour with its sample supply unit and features high-speed analytical units capable of conducting up to 900 tests per hour for the ion-selective electrode (ISE) and 1,000 tests per hour for the Cobas C 503 unit, which specializes in clinical chemistry.

In August 2023, Danaher Corporation acquired Abcam plc for $5.7 billion, aligning with Danaher's strategy to bolster its life sciences business. The acquisition of Abcam, a UK-based biotechnology company specializing in LFIA-based rapid tests, is expected to enhance value for shareholders and deliver outstanding results for both the workforce and clients.

Major companies operating in the lateral flow immunoassay (LFIA) based rapid test market include Abbott Laboratories, F. Hoffmann-La Roche, Quidel Corporation, Becton, Dickinson and Company, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hologic, Inc., LTEK Co., Ltd., JOYSBIO Biotechnology, Jiangsu Medomics Medical Technologies, Diagnocure, Ubio Biotechnology Systems, Elabscience(R) Immunoassay Kits, FyoniBio / Glycotope GmbH, Atomo Diagnostics Limited, INDICAL Bioscience, Lionex Gmbh, BIOMED Labordiagnostik GmbH, Charles River Laboratories, EKF Diagnostics, Launch Diagnostics, Diagnostic Instruments Ltd, Qiagen N.V., Merck KGaA, XPhyto Therapeutics, 3a Diagnostics, Roche Holding AG, BATM, Biomaxima, SensDx, Vitrosens Biotechnology, Bioeasy Biotechnology, Fujirebio, Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, CTK Biotech

North America was the largest region in the lateral flow immunoassay (LFIA) based rapid test market in 2024. Asia-Pacific was the second largest region in the global lateral flow immunoassay (LFIA) based rapid test market. The regions covered in the lateral flow immunoassay (LFIA) based rapid test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the lateral flow immunoassay (LFIA) based rapid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

Lateral Flow Immunoassay (LFIA) based rapid test market consists of sales of conjugate pads, nitrocellulose membrane and absorbent pad. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lateral flow immunoassay (lfia) based rapid test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lateral flow immunoassay (lfia) based rapid test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lateral flow immunoassay (lfia) based rapid test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technique: Competitive Assay, Sandwich Assay, Multiplex Detection Assay
  • 2) By Application: Infectious Disease, Pregnancy And Fertility, Toxicology, Cardiac Marker And Cholesterol Testing, Other Applications
  • 3) By End-Users: Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End Users
  • Subsegments:
  • 1) By Competitive Assay: Direct Competitive Assays; Indirect Competitive Assays
  • 2) By Sandwich Assay: Single-step Sandwich Assays; Two-step Sandwich Assays
  • 3) By Multiplex Detection Assay: Multi-analyte Assays; Simultaneous Detection Of Various Targets
  • Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche; Quidel Corporation; Becton, Dickinson and Company; Danaher Corporation; Siemens AG; Thermo Fisher Scientific Inc.; Bio-Rad Laboratories, Inc.; PerkinElmer Inc.; Hologic, Inc.; LTEK Co., Ltd.; JOYSBIO Biotechnology; Jiangsu Medomics Medical Technologies; Diagnocure; Ubio Biotechnology Systems; Elabscience(R) Immunoassay Kits; FyoniBio / Glycotope GmbH; Atomo Diagnostics Limited; INDICAL Bioscience; Lionex Gmbh; BIOMED Labordiagnostik GmbH; Charles River Laboratories; EKF Diagnostics; Launch Diagnostics; Diagnostic Instruments Ltd; Qiagen N.V.; Merck KGaA; XPhyto Therapeutics; 3a Diagnostics; Roche Holding AG; BATM; Biomaxima; SensDx; Vitrosens Biotechnology; Bioeasy Biotechnology; Fujirebio; Immunodiagnostic Systems Holdings PLC; Mesa Biotech Inc; CTK Biotech
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Characteristics

3. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Trends And Strategies

4. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Growth Rate Analysis
  • 5.4. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Total Addressable Market (TAM)

6. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Segmentation

  • 6.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Competitive Assay
  • Sandwich Assay
  • Multiplex Detection Assay
  • 6.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Disease
  • Pregnancy & Fertility
  • Toxicology
  • Cardiac Marker And Cholesterol Testing
  • Other Applications
  • 6.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital & Clinic
  • Diagnostic Laboratory
  • Home Care
  • Other End Users
  • 6.4. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Competitive Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Competitive Assays
  • Indirect Competitive Assays
  • 6.5. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Sandwich Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-step Sandwich Assays
  • Two-step Sandwich Assays
  • 6.6. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Multiplex Detection Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Multi-analyte Assays
  • Simultaneous Detection Of Various Targets

7. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Regional And Country Analysis

  • 7.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 8.1. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 9.1. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 9.2. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 10.1. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 11.1. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 11.2. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 12.1. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 13.1. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 14.1. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 14.2. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 15.1. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 15.2. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 16.1. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 17.1. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 18.1. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 19.1. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 20.1. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 21.1. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 21.2. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 22.1. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 23.1. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 23.2. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 24.1. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 24.2. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 25.1. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 25.2. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 26.1. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 26.2. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 27.1. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 28.1. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 28.2. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 29.1. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 29.2. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape And Company Profiles

  • 30.1. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape
  • 30.2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Other Major And Innovative Companies

  • 31.1. Siemens AG
  • 31.2. Thermo Fisher Scientific Inc.
  • 31.3. Bio-Rad Laboratories, Inc.
  • 31.4. PerkinElmer Inc.
  • 31.5. Hologic, Inc.
  • 31.6. LTEK Co., Ltd.
  • 31.7. JOYSBIO Biotechnology
  • 31.8. Jiangsu Medomics Medical Technologies
  • 31.9. Diagnocure
  • 31.10. Ubio Biotechnology Systems
  • 31.11. Elabscience(R) Immunoassay Kits
  • 31.12. FyoniBio / Glycotope GmbH
  • 31.13. Atomo Diagnostics Limited
  • 31.14. INDICAL Bioscience
  • 31.15. Lionex Gmbh

32. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

34. Recent Developments In The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

35. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market High Potential Countries, Segments and Strategies

  • 35.1 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer